| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |